Researchers Find Key to Healthy Heartbeats

A tiny region in a little-known muscle protein may hold the key to a healthy, steady heartbeat.

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

Researchers at Washington State University have discovered a region of a protein called leiomodin that is critical in maintaining the length of tiny filaments that control a person's heartbeat. This finding could provide clues to future treatment of devastating heart ailments like cardiomyopathy, where genetic mutations result in filaments that are either too short or too long, causing significant heart problems.

Why it matters

A uniform heart muscle filament length is important for a healthy heartbeat, but the filaments constantly renew their protein structures throughout a lifetime and need to maintain a consistent length. Mutations in the proteins that regulate filament length, like leiomodin and tropomodulin, can lead to cardiomyopathies and other serious heart issues.

The details

The researchers found that one region of the leiomodin protein plays a particularly important role in binding to the actin filaments and demonstrated its molecular mechanism. They discovered that leiomodin's weaker binding allows it to be removed when the actin starts building a protein chain, which helps regulate filament length. Making mutations to weaken this binding site even further resulted in very long, thin filaments.

  • The research findings were published in the journal Circulation Research in 2026.

The players

Alla Kostyukova

Professor in the Gene and Linda Voiland School of Chemical Engineering and Bioengineering at Washington State University and one of the study's lead researchers.

Carol Gregorio

Collaborator at Icahn School of Medicine at Mount Sinai who tested the small region of the leiomodin protein and verified its behavior in animal cells.

Garry Smith

Researcher at Washington State University who contributed to the study.

Dmitri Tolkachev

Assistant professor in the Voiland School at Washington State University who contributed to the study.

Got photos? Submit your photos here. ›

What they’re saying

“It's a small part of a big protein that turned out to be extremely important for its function in the elongation of thin filaments.”

— Alla Kostyukova, Professor (Mirage News)

“In many cardiomyopathies, the length of the thin filaments is wrong. It always has to be the correct length. If you have a mutation in one of these proteins, your heart cannot work properly.”

— Alla Kostyukova, Professor (Mirage News)

“For leiomodin, it's a weaker binding, and that's why it was believed that it probably wasn't binding at all. But we demonstrated that it binds forming a so-called 'leaky cap,' and this weaker binding allows it to be removed when the actin starts polymerizing, or building a protein chain. When you make mutations in the binding site to make it even weaker, it makes really long, thin filaments.”

— Alla Kostyukova, Professor (Mirage News)

What’s next

The researchers aim to continue gathering information about cardiac proteins, understanding how the binding sites of leiomodin and other proteins work together in the filament elongation process. Their hope is to eventually work with small molecules to improve these proteins when they have pathogenic mutations.

The takeaway

This discovery of a key region in the leiomodin protein that regulates the length of heart muscle filaments provides important insights that could lead to new treatments for devastating heart conditions caused by genetic mutations affecting filament length.